BETA
Home MEPs Dossiers Committees Subjects Blog About Dumps
download json


2018/0118(NLE) Subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures

Progress: Awaiting final decision

RoleCommitteeRapporteurShadows
Lead LIBE ŠKRIPEK Branislav (icon: ECR ECR) HORTEFEUX Brice (icon: PPE PPE), HEDH Anna (icon: S&D S&D), PAGAZAURTUNDÚA Maite (icon: ALDE ALDE)
Lead committee dossier:

Events

2018/09/11
   EP - Decision by Parliament
Details

The European Parliament adopted by 635 votes to 11, with 37 abstentions, following the consultation procedure, a legislative resolution on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

Parliament approved the Council draft which aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

Text adopted by Parliament, 1st reading/single reading

Documents
T8-0320/2018
2018/09/11
   EP - Results of vote in Parliament
Documents
Results of vote in Parliament
2018/09/03
   EP - Committee report tabled for plenary, 1st reading/single reading
Details

The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Branislav ŠKRIPEK (ECR, SK) on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

The committee recommended that Parliament approve the Council draft .

The risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

Committee report tabled for plenary, 1st reading/single reading

Documents
A8-0271/2018
2018/08/30
   EP - Vote in committee
2018/07/02
   EP - Committee referral announced in Parliament
2018/06/21
   European Parliament - Committee draft report
Documents
PE623.813
2018/06/20
   EP - ŠKRIPEK Branislav (ECR) appointed as rapporteur in LIBE
2018/06/11
   EC - Legislative proposal published
Details

PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

PROPOSED ACT: Council Implementing Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.

Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.

Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.

Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.

The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

CONTENT: the draft Council implementing decision aims to subject the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide ('cyclopropylfentanyl') and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide ('methoxyacetylfentanyl') to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

Legislative proposal

Documents
09420/2018
2018/04/30
   European Commission - Initial legislative proposal
Details

PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

PROPOSED ACT: Council Implementing Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.

Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.

Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.

Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.

The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

CONTENT: the draft Council decision aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl) to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

Initial legislative proposal

Documents
COM(2018)0253
Go to the pageEur-Lex
2018/04/30
   EC - Initial legislative proposal published
Details

PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

PROPOSED ACT: Council Implementing Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.

Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.

Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.

Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.

The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

CONTENT: the draft Council decision aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl) to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

Initial legislative proposal

Documents
COM(2018)0253
Go to the page Eur-Lex

Documents

Votes

A8-0271/2018 - Branislav Škripek - Vote unique 11/09/2018 12:43:06.000 #

2018/09/11 Outcome: +: 635, 0: 37, -: 11
DE FR IT ES PL GB RO CZ BE HU PT AT SE NL EL BG SK FI DK HR LT SI EE IE CY MT LU LV ??
Total
85
64
64
49
51
67
28
21
20
20
18
18
18
25
17
15
13
12
11
10
9
8
6
8
6
6
5
5
2
icon: PPE PPE
202

Germany PPE

28

France PPE

19

Italy PPE

14

Spain PPE

17

Poland PPE

22

United Kingdom PPE

2

Romania PPE

12

Czechia PPE

7

Belgium PPE

4

Hungary PPE

12

Portugal PPE

6

Austria PPE

5

Sweden PPE

3

Netherlands PPE

5

Greece PPE

4

Bulgaria PPE

7

Slovakia PPE

6

Finland PPE

2

Denmark PPE

For (1)

Bendt BENDTSEN
1

Croatia PPE

4

Lithuania PPE

3

Slovenia PPE

5

Estonia PPE

For (1)

Tunne KELAM
1

Ireland PPE

4

Cyprus PPE

1

Malta PPE

3

Luxembourg PPE

2

Latvia PPE

3
icon: S&D S&D
171

Germany S&D

24

France S&D

12

Italy S&D

27

Spain S&D

13

Poland S&D

5

United Kingdom S&D

20

Romania S&D

11

Czechia S&D

4

Belgium S&D

4

Hungary S&D

3

Portugal S&D

7

Austria S&D

5

Sweden S&D

6

Netherlands S&D

For (2)

Kati PIRI, Paul TANG
2

Greece S&D

3

Bulgaria S&D

3

Slovakia S&D

4

Finland S&D

2

Denmark S&D

3

Croatia S&D

2

Lithuania S&D

1

Slovenia S&D

For (1)

Tanja FAJON
1

Estonia S&D

For (1)

Ivari PADAR
1

Ireland S&D

For (1)

Nessa CHILDERS
1

Cyprus S&D

2

Malta S&D

3

Luxembourg S&D

For (1)

Mady DELVAUX
1

Latvia S&D

1
icon: ALDE ALDE
64

Germany ALDE

3

France ALDE

7

Spain ALDE

8

United Kingdom ALDE

1

Romania ALDE

3

Czechia ALDE

4

Belgium ALDE

6

Portugal ALDE

1

Austria ALDE

For (1)

Angelika MLINAR
1

Sweden ALDE

2

Netherlands ALDE

7

Bulgaria ALDE

3

Finland ALDE

4

Denmark ALDE

2

Croatia ALDE

2

Lithuania ALDE

3

Slovenia ALDE

For (1)

Ivo VAJGL
1

Estonia ALDE

3

Ireland ALDE

For (1)

Marian HARKIN
1

Luxembourg ALDE

For (1)

Charles GOERENS
1

Latvia ALDE

1
icon: ECR ECR
70

Germany ECR

6

Italy ECR

2

Poland ECR

18

United Kingdom ECR

19

Romania ECR

2

Czechia ECR

2

Belgium ECR

3

Sweden ECR

2

Netherlands ECR

2

Greece ECR

For (1)

Notis MARIAS
1

Bulgaria ECR

2

Slovakia ECR

3

Finland ECR

2

Denmark ECR

3

Croatia ECR

For (1)

Ruža TOMAŠIĆ
1

Lithuania ECR

1

Cyprus ECR

1
icon: Verts/ALE Verts/ALE
45

Germany Verts/ALE

13

France Verts/ALE

4

Italy Verts/ALE

For (1)

Marco AFFRONTE
1

Spain Verts/ALE

2

United Kingdom Verts/ALE

5

Belgium Verts/ALE

2

Hungary Verts/ALE

2

Austria Verts/ALE

3

Sweden Verts/ALE

4

Netherlands Verts/ALE

2

Finland Verts/ALE

For (1)

Heidi HAUTALA
1

Denmark Verts/ALE

For (1)

Margrete AUKEN
1

Croatia Verts/ALE

For (1)

Davor ŠKRLEC
1

Lithuania Verts/ALE

For (1)

Bronis ROPĖ
1

Slovenia Verts/ALE

For (1)

Igor ŠOLTES
1

Estonia Verts/ALE

For (1)

Indrek TARAND
1

Luxembourg Verts/ALE

For (1)

Tilly METZ
1
icon: GUE/NGL GUE/NGL
43

Germany GUE/NGL

7

France GUE/NGL

3

Italy GUE/NGL

2

Spain GUE/NGL

9

United Kingdom GUE/NGL

1

Czechia GUE/NGL

3

Portugal GUE/NGL

4

Sweden GUE/NGL

For (1)

Malin BJÖRK
1

Netherlands GUE/NGL

3

Greece GUE/NGL

4

Finland GUE/NGL

For (1)

Merja KYLLÖNEN
1

Denmark GUE/NGL

For (1)

Rina Ronja KARI
1

Ireland GUE/NGL

For (1)

Matt CARTHY

Against (1)

Luke Ming FLANAGAN
2

Cyprus GUE/NGL

2
icon: ENF ENF
30

Germany ENF

Abstain (1)

Marcus PRETZELL
1

France ENF

13

Italy ENF

5

Poland ENF

2

Belgium ENF

For (1)

Gerolf ANNEMANS
1

Austria ENF

4

Netherlands ENF

4
icon: EFDD EFDD
37

Germany EFDD

Abstain (1)

Jörg MEUTHEN
1

France EFDD

5

Italy EFDD

Abstain (1)

Giulia MOI
13

Poland EFDD

1

United Kingdom EFDD

15

Czechia EFDD

Abstain (1)

Jiří PAYNE
1

EFDD

Abstain (1)

Sophie MONTEL
1
icon: NI NI
19

Germany NI

Against (1)

Udo VOIGT
2

France NI

For (1)

Bruno GOLLNISCH
1

Poland NI

Against (1)

Dobromir SOŚNIERZ
3

United Kingdom NI

Against (1)

Steven WOOLFE
4

Hungary NI

3

Greece NI

5

NI

For (1)

David BORRELLI
1

History

(these mark the time of scraping, not the official date of the change)

2024-12-18Show (15) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: European Conservatives and Reformists Group abbr: ECR
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: European Conservatives and Reformists abbr: ECR
shadows
docs/0/body
Old
EP
New
European Parliament
docs/1
date
2018-04-30T00:00:00
docs
summary
type
Initial legislative proposal
body
European Commission
events/0
date
2018-04-30T00:00:00
type
Initial legislative proposal published
body
EC
docs
summary
events/0
date
2018-04-30T00:00:00
type
Initial legislative proposal published
body
EC
docs
summary
events/1/summary/10
Legislative proposal
events/4/summary/4
Committee report tabled for plenary, 1st reading/single reading
events/5
date
2018-09-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=31453&l=en title: Results of vote in Parliament
events/5
date
2018-09-11T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.html title: T8-0320/2018
summary
events/5/summary/2
Text adopted by Parliament, 1st reading/single reading
events/6
date
2018-09-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=31453&l=en title: Results of vote in Parliament
events/6
date
2018-09-11T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.html title: T8-0320/2018
summary
events/6/docs/0/url
Old
https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=31453&l=en
New
https://oeil.secure.europarl.europa.eu/oeil/en/sda-vote-result?sdaId=31453
procedure/dossier_of_the_committee
Old
  • LIBE/8/13013
New
LIBE/8/13013
2024-10-13Show (1) Changes | Timetravel
procedure/Other legal basis
Old
Rules of Procedure EP 159
New
Rules of Procedure EP 165
2024-10-12Show (1) Changes | Timetravel
procedure/Other legal basis
Old
Rules of Procedure EP 159
New
Rules of Procedure EP 165
2024-01-30Show (4) Changes | Timetravel
docs/0
date
2018-04-30T00:00:00
docs
summary
type
Initial legislative proposal
body
EC
docs/1
date
2018-06-11T00:00:00
docs
url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=9420%2F18&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 09420/2018
summary
type
Legislative proposal
body
CSL
events/0/date
Old
2018-04-29T00:00:00
New
2018-04-30T00:00:00
events/1/date
Old
2018-06-10T00:00:00
New
2018-06-11T00:00:00
2022-06-18Show (8) Changes | Timetravel
committees/0/shadows/3
name
ANDERSON Martina
group
European United Left - Nordic Green Left
abbr
GUE/NGL
docs/0
date
2018-06-21T00:00:00
docs
title: PE623.813
type
Committee draft report
body
EP
docs/0
date
2018-04-30T00:00:00
docs
summary
type
Initial legislative proposal
body
EC
docs/1
date
2018-06-11T00:00:00
docs
url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=9420%2F18&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 09420/2018
summary
type
Legislative proposal
body
CSL
docs/2
date
2018-06-21T00:00:00
docs
title: PE623.813
type
Committee draft report
body
EP
docs/2/docs/0/url
https://www.europarl.europa.eu/doceo/document/LIBE-PR-623813_EN.html
events/0/date
Old
2018-04-30T00:00:00
New
2018-04-29T00:00:00
events/1/date
Old
2018-06-11T00:00:00
New
2018-06-10T00:00:00
2021-05-03Show (3) Changes | Timetravel
events/2/body
EP
events/3/body
EP
events/6/body
EP
2021-04-24Show (7) Changes | Timetravel
docs/0/docs/0/url
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE623.813
events/2
date
2018-07-02T00:00:00
type
Committee referral announced in Parliament
events/2
date
2018-07-02T00:00:00
type
Committee referral announced in Parliament, 1st reading/single reading
body
EP
events/3
date
2018-08-30T00:00:00
type
Vote in committee
events/3
date
2018-08-30T00:00:00
type
Vote in committee, 1st reading/single reading
body
EP
events/6
date
2018-09-11T00:00:00
type
Decision by Parliament
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.html title: T8-0320/2018
summary
events/6
date
2018-09-11T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.html title: T8-0320/2018
summary
2021-03-03Show (2) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: European Conservatives and Reformists abbr: ECR
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: ??? abbr: Unknown Group
shadows
2021-02-24Show (2) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: ??? abbr: Unknown Group
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: ??? abbr: Unknown Group
shadows
2021-02-17Show (2) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: ??? abbr: Unknown Group
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: ??? abbr: Unknown Group
shadows
2021-02-16Show (2) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: ??? abbr: Unknown Group
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: European Conservatives and Reformists abbr: ECR
shadows
2020-12-09Show (2) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: European Conservatives and Reformists abbr: ECR
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: European Conservatives and Reformists abbr: ECR
shadows
2020-11-18Show (2) Changes | Timetravel
procedure/Modified legal basis
Rules of Procedure EP 159
procedure/Other legal basis
Rules of Procedure EP 159
2020-08-10Show (3) Changes | Timetravel
docs/0/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE623.813
New
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE623.813
events/4/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/A-8-2018-0271_EN.html
New
https://www.europarl.europa.eu/doceo/document/A-8-2018-0271_EN.html
events/6/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.html
New
https://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.html
2020-01-07Show (2) Changes | Timetravel
events/4/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2018-0271&language=EN
New
http://www.europarl.europa.eu/doceo/document/A-8-2018-0271_EN.html
events/6/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2018-0320
New
http://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.html
2019-08-07Show (2) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: ŠKRIPEK Branislav date: 2018-06-20T00:00:00 group: European Conservatives and Reformists abbr: ECR
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2018-06-20T00:00:00
rapporteur
name: ŠKRIPEK Branislav group: European Conservatives and Reformists abbr: ECR
shadows
2019-07-10Show (1) Changes | Timetravel
events/5
date
2018-09-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=31453&l=en title: Results of vote in Parliament
2019-07-06Show (13) Changes | Timetravel
activities
  • date: 2018-04-30T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2018/0253/COM_COM(2018)0253_EN.pdf title: COM(2018)0253 type: Initial legislative proposal published celexid: CELEX:52018PC0253:EN body: EC commission: DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type: Initial legislative proposal published
  • date: 2018-06-11T00:00:00 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=9420%2F18&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 09420/2018 body: EC commission: DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type: Legislative proposal published
  • date: 2018-07-02T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
  • date: 2018-08-30T00:00:00 body: EP type: Vote in committee, 1st reading/single reading committees: body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
  • body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2018-0271&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0271/2018 type: Committee report tabled for plenary, 1st reading/single reading committees: body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav date: 2018-09-03T00:00:00
  • date: 2018-09-11T00:00:00 body: EP type: Vote in plenary scheduled
commission
  • body: EC dg: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2018-06-20T00:00:00
rapporteur
name: ŠKRIPEK Branislav group: European Conservatives and Reformists abbr: ECR
shadows
committees/0
body
EP
shadows
responsible
True
committee
LIBE
date
2018-06-20T00:00:00
committee_full
Civil Liberties, Justice and Home Affairs
rapporteur
group: ECR name: ŠKRIPEK Branislav
docs
  • date: 2018-06-21T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE623.813 title: PE623.813 type: Committee draft report body: EP
events
  • date: 2018-04-30T00:00:00 type: Initial legislative proposal published body: EC docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2018/0253/COM_COM(2018)0253_EN.pdf title: COM(2018)0253 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2018&nu_doc=0253 title: EUR-Lex summary: PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures. PROPOSED ACT: Council Implementing Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018. They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals. Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed. Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed. Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays. The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union. CONTENT: the draft Council decision aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl) to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.
  • date: 2018-06-11T00:00:00 type: Legislative proposal published body: EC docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=9420%2F18&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 09420/2018 summary: PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures. PROPOSED ACT: Council Implementing Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018. They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals. Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed. Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed. Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays. The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union. CONTENT: the draft Council implementing decision aims to subject the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide ('cyclopropylfentanyl') and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide ('methoxyacetylfentanyl') to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.
  • date: 2018-07-02T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
  • date: 2018-08-30T00:00:00 type: Vote in committee, 1st reading/single reading body: EP
  • date: 2018-09-03T00:00:00 type: Committee report tabled for plenary, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2018-0271&language=EN title: A8-0271/2018 summary: The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Branislav ŠKRIPEK (ECR, SK) on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures. The committee recommended that Parliament approve the Council draft . The risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018. The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.
  • date: 2018-09-11T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2018-0320 title: T8-0320/2018 summary: The European Parliament adopted by 635 votes to 11, with 37 abstentions, following the consultation procedure, a legislative resolution on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures. Parliament approved the Council draft which aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.
links
other
  • body: EC dg: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
procedure/Modified legal basis
Old
Rules of Procedure EP 150
New
Rules of Procedure EP 159
procedure/dossier_of_the_committee
Old
LIBE/8/13013
New
  • LIBE/8/13013
procedure/instrument
Decision
procedure/stage_reached
Old
Awaiting Parliament 1st reading / single reading / budget 1st stage
New
Awaiting final decision
procedure/subject
Old
  • 7.30.30.04 Action to combat drugs and drug-trafficking
New
7.30.30.04
Action to combat drugs and drug-trafficking
2018-09-12Show (14) Changes | Timetravel
activities/0/docs/0/text

  • PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.

    PROPOSED ACT: Council Implementing Decision.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

    BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.

    They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.

    Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.

    Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.

    Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.

    The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.

    CONTENT: the draft Council decision aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl) to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.

activities/0/docs/0/type
Old
Legislative proposal published
New
Initial legislative proposal published
activities/0/type
Old
Legislative proposal published
New
Initial legislative proposal published
activities/1
date
2018-06-11T00:00:00
docs
url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=9420%2F18&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 09420/2018
type
Legislative proposal published
body
EC
commission
DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
activities/2
date
2018-07-02T00:00:00
body
EP
type
Committee referral announced in Parliament, 1st reading/single reading
committees
body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
activities/3
date
2018-08-30T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
activities/4
body
EP
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2018-0271&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0271/2018
type
Committee report tabled for plenary, 1st reading/single reading
committees
body: EP shadows: group: EPP name: HORTEFEUX Brice group: S&D name: HEDH Anna group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite group: GUE/NGL name: ANDERSON Martina responsible: True committee: LIBE date: 2018-06-20T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: ECR name: ŠKRIPEK Branislav
date
2018-09-03T00:00:00
activities/5
date
2018-09-11T00:00:00
body
EP
type
Vote in plenary scheduled
committees/0/date
2018-06-20T00:00:00
committees/0/rapporteur
  • group: ECR name: ŠKRIPEK Branislav
committees/0/shadows
  • group: EPP name: HORTEFEUX Brice
  • group: S&D name: HEDH Anna
  • group: ALDE name: PAGAZAURTUNDÚA RUIZ Maite
  • group: GUE/NGL name: ANDERSON Martina
procedure/Modified legal basis
Rules of Procedure EP 150
procedure/dossier_of_the_committee
LIBE/8/13013
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting Parliament 1st reading / single reading / budget 1st stage
2018-05-09Show (5) Changes
activities
  • date: 2018-04-30T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2018/0253/COM_COM(2018)0253_EN.pdf celexid: CELEX:52018PC0253:EN type: Legislative proposal published title: COM(2018)0253 type: Legislative proposal published body: EC commission: DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
committees
  • body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
links
other
  • body: EC dg: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
procedure
reference
2018/0118(NLE)
title
Subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures
stage_reached
Preparatory phase in Parliament
subtype
Consultation of Parliament
type
NLE - Non-legislative enactments
subject
7.30.30.04 Action to combat drugs and drug-trafficking
@parltrack
@parltrack@eupolicy.social
[javascript protected email address]
code AGPLv3.0+
data ODBLv1.0
site content CC-By-Sa-3.0

ParlTrack - 2011-2024

© European Union, 2011 – Source: European Parliament
Hosted by AS250.net Foundation